APA (7th ed.) Citation

TB, K., EG, C., SM, S., & PJ, O. (2019). A Phase I Study of GGTI-2418 (Geranylgeranyl Transferase I Inhibitor) in Patients with Advanced Solid Tumors. Targeted oncology, 14(5), 613. https://doi.org/10.1007/s11523-019-00661-5

Chicago Style (17th ed.) Citation

TB, Karasic, Chiorean EG, Sebti SM, and O'Dwyer PJ. "A Phase I Study of GGTI-2418 (Geranylgeranyl Transferase I Inhibitor) in Patients with Advanced Solid Tumors." Targeted Oncology 14, no. 5 (2019): 613. https://doi.org/10.1007/s11523-019-00661-5.

MLA (9th ed.) Citation

TB, Karasic, et al. "A Phase I Study of GGTI-2418 (Geranylgeranyl Transferase I Inhibitor) in Patients with Advanced Solid Tumors." Targeted Oncology, vol. 14, no. 5, 2019, p. 613, https://doi.org/10.1007/s11523-019-00661-5.